Type 1 Diabetes

By Dave Muoio 11:40 am June 3, 2019
T1D Exchange, a Boston-based nonprofit that promotes Type 1 diabetes research, has announced the launch of an open online patient data registry. By collecting information from children and adults with the condition, the group hopes to build a substantial longitudinal cohort that will drive new treatment development research and influence new policy or reimbursement decisions. After creating an...
By Dave Muoio 02:55 pm May 28, 2019
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range. Collected from nearly 8 million days of recorded system use and announced by Medtronic today in a press release, the new findings also suggest that this rate increased further for those who employed...
By Dave Muoio 03:32 pm January 28, 2019
A recent paper published in Diabetes Technology & Therapeutics describes the design, safety and basic efficacy of a device-agnostic smartphone app that can interface with continuous glucose monitors, insulin pump devices and dosing algorithms from various manufacturers. Run on an unlocked smartphone, the interoperable Artificial Pancreas System (iAPS) smartphone app was reliable and generally...
By Laura Lovett 03:35 pm December 13, 2018
Diabetes management startup Tidepool has just locked in a $6 million grant from the Leona M. and Harry B. Helmsley Charitable Trust and JDRF in order to kick off develop an app for hybrid closed-loop automated insulin delivery.  Eventually the company plans to bring the software to market as an FDA-regulated mobile app. Right now the plans are to build an app that is specifically designed to help...
By Laura Lovett 12:56 pm November 1, 2018
Klue, a startup that uses gesture monitoring to track eating behaviors, is turning its attention to Type 1 diabetes. This afternoon the San Francisco-based startup announced that its platform will now include a reminder feature designed specifically to help people with Type 1 diabetes manage their condition around meals.  “The module will send the users a gentle nudge on their Apple Watch when...
By Dave Muoio 11:46 am October 3, 2018
Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing their own glucose levels with an insulin pump and continuous glucose monitor, according to a study published today in the Lancet. The investigation, which was supported by JDRF and presented at the...
By Jonah Comstock 04:38 pm August 23, 2018
Evidation Health is teaming up with Tidepool to launch a connected device-powered study of nocturnal hypoglycemic events in people with Type 1 diabetes.  The research is novel in that connected devices — including Dexcom continuous glucose monitors, an Emfit sleep monitor, and a WHOOP activity tracker — will allow researchers to access data about overnight low blood sugar events that previously...
By Laura Lovett 11:11 am June 22, 2018
Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a younger demographic.  In 2016 the device became the first FDA-approved continuous glucose monitoring system that controls automated insulin delivery via a hybrid closed loop system. But at that time...
By Dave Muoio 01:20 pm March 20, 2018
Data from a team of Dutch researchers presented this weekend at the Endocrinology Society’s annual meeting in Chicago demonstrated how vital monitoring wearables could identify Type 1 diabetes patients’ hypoglycemic events by measuring heart rate. The pilot study outfitted 27 adult patients with VitalConnect’s HealthPatch MD, a continuous health monitor that the company has since replaced with...
By Dave Muoio 02:52 pm February 26, 2018
The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm. The sensor is part of Medtronic’s MiniMed 670G system, and is currently the only continuous glucose monitor approved by the FDA to control automated insulin delivery via a hybrid closed loop system. Along with the added convenience of the new sensor site, the company...